In-house and commercial FMT products effectively accelerate clinical recovery from canine parvovirus infection, suggesting improved care options.
In-house and commercially available FMT products were effective in CPV-infected dogs, thus broadening the spectrum of care available to these patients.
No takes yet. Share an insight, caveat, or question.
Winston et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: